
In the last week, the Medical Equipment industry is up 3.6%, with Hangzhou Diagens Biotechnology up 24%. During this same period, the Shenzhen Edge Medical underperformed, falling 5.6%. This takes the industry's 12 month performance to a gain of 28%. Looking forward, earnings are forecast to grow by 49% annually.
Has the Hong Kong Medical Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 14 Apr 2026 | HK$245.3b | HK$66.0b | HK$2.5b | 16.5x | 98.4x | 3.7x |
| Thu, 12 Mar 2026 | HK$229.7b | HK$64.0b | HK$2.4b | 16.2x | 96.3x | 3.6x |
| Sat, 07 Feb 2026 | HK$237.4b | HK$63.5b | HK$2.3b | 18.4x | 101.5x | 3.7x |
| Mon, 05 Jan 2026 | HK$201.4b | HK$62.7b | HK$2.5b | 19.8x | 80.3x | 3.2x |
| Wed, 03 Dec 2025 | HK$215.6b | HK$63.4b | HK$3.1b | 19.4x | 69.6x | 3.4x |
| Fri, 31 Oct 2025 | HK$220.8b | HK$62.8b | HK$3.0b | 20x | 74.4x | 3.5x |
| Sun, 28 Sep 2025 | HK$215.6b | HK$62.8b | HK$3.0b | 20.2x | 72.8x | 3.4x |
| Tue, 26 Aug 2025 | HK$234.1b | HK$62.3b | HK$3.4b | 24.9x | 68.6x | 3.8x |
| Thu, 24 Jul 2025 | HK$201.3b | HK$62.1b | HK$3.2b | 20.1x | 62.3x | 3.2x |
| Sat, 21 Jun 2025 | HK$179.4b | HK$62.0b | HK$3.2b | 22x | 55.7x | 2.9x |
| Mon, 19 May 2025 | HK$164.2b | HK$61.6b | HK$3.2b | 21.2x | 51.5x | 2.7x |
| Wed, 16 Apr 2025 | HK$155.6b | HK$60.6b | HK$3.1b | 20.2x | 50x | 2.6x |
| Fri, 14 Mar 2025 | HK$164.6b | HK$58.6b | HK$573.9m | 20.7x | 286.8x | 2.8x |
| Sun, 09 Feb 2025 | HK$147.4b | HK$58.0b | HK$1.2b | 17.7x | 124.5x | 2.5x |
| Tue, 07 Jan 2025 | HK$133.3b | HK$57.7b | HK$1.2b | 16.1x | 114.4x | 2.3x |
| Thu, 05 Dec 2024 | HK$133.5b | HK$58.1b | HK$1.2b | 15.3x | 111.9x | 2.3x |
| Sat, 02 Nov 2024 | HK$134.8b | HK$58.8b | HK$1.3b | 15.7x | 106.3x | 2.3x |
| Mon, 30 Sep 2024 | HK$137.4b | HK$59.5b | HK$1.3b | 13.6x | 103x | 2.3x |
| Wed, 28 Aug 2024 | HK$117.3b | HK$55.4b | -HK$737,667,383.64 | 11.6x | -159.1x | 2.1x |
| Fri, 26 Jul 2024 | HK$117.0b | HK$54.1b | -HK$1,089,229,853.16 | 12.4x | -107.4x | 2.2x |
| Sun, 23 Jun 2024 | HK$128.3b | HK$53.9b | -HK$1,095,953,290.75 | 12.9x | -117.1x | 2.4x |
| Tue, 21 May 2024 | HK$158.7b | HK$54.0b | -HK$1,088,546,652.96 | 15.7x | -145.8x | 2.9x |
| Thu, 18 Apr 2024 | HK$140.8b | HK$54.2b | -HK$1,094,350,942.54 | 13.6x | -128.6x | 2.6x |
| Sat, 16 Mar 2024 | HK$155.0b | HK$52.7b | -HK$1,043,514,658.89 | 12.2x | -148.6x | 2.9x |
| Mon, 12 Feb 2024 | HK$151.3b | HK$53.4b | -HK$2,428,876,600.47 | 11.7x | -62.3x | 2.8x |
| Wed, 10 Jan 2024 | HK$185.5b | HK$53.7b | -HK$2,339,229,345.00 | 14x | -79.3x | 3.5x |
| Fri, 08 Dec 2023 | HK$195.5b | HK$53.7b | -HK$2,341,108,526.00 | 15.6x | -83.5x | 3.6x |
| Sun, 05 Nov 2023 | HK$209.6b | HK$52.9b | -HK$2,342,093,159.00 | 21x | -89.5x | 4x |
| Tue, 03 Oct 2023 | HK$209.2b | HK$52.9b | -HK$2,346,270,030.00 | 15.8x | -89.2x | 4x |
| Thu, 31 Aug 2023 | HK$218.5b | HK$52.0b | -HK$3,323,663,867.00 | 15.2x | -65.7x | 4.2x |
| Sat, 29 Jul 2023 | HK$257.0b | HK$51.2b | -HK$3,933,517,118.00 | 20.5x | -65.3x | 5x |
| Mon, 26 Jun 2023 | HK$231.5b | HK$51.2b | -HK$3,947,583,322.00 | 18.8x | -58.6x | 4.5x |
| Wed, 24 May 2023 | HK$268.6b | HK$51.9b | -HK$3,966,368,127.00 | 20.6x | -67.7x | 5.2x |
| Fri, 21 Apr 2023 | HK$305.8b | HK$53.2b | -HK$4,235,221,948.00 | 23.5x | -72.2x | 5.7x |
-72.2x
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 1.79% | |
| Healthcare | -2.51% | |
| Medical Equipment | 3.64% | |
| Medical Equipment | 3.70% | |
| Medical Supplies | 3.45% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2252 Shanghai MicroPort MedBot (Group) | HK$30.30 | 14.5% +HK$4.0b | 85.2% | PS49.4x | |
| 2526 Hangzhou Diagens Biotechnology | HK$277.00 | 18.4% +HK$3.8b | n/a | PS130.3x | |
| 2276 Shanghai Conant Optical | HK$47.60 | 12.0% +HK$2.6b | 103.0% | PE37.7x | |
| 6699 Angelalign Technology | HK$85.35 | 9.8% +HK$1.3b | 75.4% | PE65.5x | |
| 1501 Shanghai INT Medical Instruments | HK$40.00 | 17.2% +HK$1.2b | 49.5% | PE35.4x |